Doximity, Inc.

Doximity is a digital platform for U.S. medical professionals that connects physicians and other clinicians with tools for professional networking, workflow, telehealth, and career management. It monetizes that network by selling subscription-based Marketing Solutions, Hiring Solutions, and Workflow Solutions to pharmaceutical manufacturers, health systems, and recruiting customers.

35,6 %

89,1 %

30,4 %

+13,1 %

6.09

6.09

— Doximity, Inc.
%
Marketing Solutions60% Subscription modules that let pharma and health system customers target tailored content and peer connections to medical professionals.
Hiring Solutions20% Digital recruiting and staffing tools used by health systems and medical recruiting firms to source clinicians.
Workflow Solutions15% Telehealth, on-call scheduling, and AI workflow products that help clinicians streamline daily work.
Curative Talent and other services5% Personalized staffing and related service offerings that complement the core platform.

Doximity sells primarily to pharmaceutical manufacturers and health systems, while also serving medical recruiting...

  • Pharmaceutical manufacturersprimary

    Buy Marketing Solutions subscriptions to deliver tailored content and campaigns to targeted medical professionals.

  • Health systems and hospitalsprimary

    Buy Marketing, Hiring, and Workflow Solutions to recruit clinicians, market services, and improve clinical operations.

  • Medical recruiting firmssecondary

    Use Hiring Solutions to identify and connect with clinician candidates through Doximity's network.

  • Clinicians and physicians as membersprimary

    Do not directly pay for the core platform, but their engagement is essential because it drives customer value.

Doximity is overwhelmingly a U.S.-focused business, with its platform, members, and customers centered on the United...

  • Business is centered in the United States
  • Members are primarily U.S. physicians and clinicians
  • Customers are U.S. pharma companies and health systems
  • No country-level revenue split was disclosed in the excerpts
  • Limited geographic diversification increases U.S. regulatory exposure

Doximity is focused on deepening engagement across its member network so it can sell more solutions to existing...

01
Grow member network and engagementshort-term

Customer value depends on broad physician usage and active engagement on the platform.

02
Expand revenue from existing customersshort-term

The business is concentrated in a relatively small number of key customers, so upsell and renewal matter.

03
Invest in product and infrastructuremedium-term

Platform reliability, cloud hosting, and new tools are needed to sustain growth and competitiveness.

Doximity faces concentration risk because revenue depends on a relatively small number of large customers, even though...

high

Customer concentration

Revenue is relatively concentrated among a small number of key customers, so losing one could slow growth or reduce revenue.

Scope
Pharmaceutical manufacturers and health systems
Materiality
high
high

Intense competition

The company competes for members and for customer budgets against larger and better-resourced firms.

Scope
Marketing, Hiring, and Workflow Solutions
Materiality
high
high

Platform and cybersecurity risk

The business depends on cloud infrastructure, apps, and websites that must remain secure and reliable.

Scope
AWS, apps, websites, member data
Materiality
high
medium

Privacy and healthcare regulation

Handling clinician and customer data exposes the company to changing privacy and information security rules.

Scope
Healthcare data and digital marketing workflows
Materiality
high
Revenue recognition over time
Can shift revenue between quarters and create balance sheet contract assets
Unbilled revenue and contract assets
Important for understanding working capital and collections
Internal-use software capitalization
Can smooth near-term expenses while increasing future amortization
Goodwill and acquired intangibles
Potential impairment charges if acquired businesses underperform

: 28/04/2026